论文部分内容阅读
目的观察黄芪注射液辅助治疗小儿病毒性心肌炎的临床疗效。方法将我院收治的病毒性心肌炎患儿64例,分为对照组和观察组各32例,对照组应用单纯西医疗法,观察组在对照组治疗基础上给予黄芪注射液治疗,均治疗1个月后,比较两组治疗前后LDH、AST和CK的变化情况。结果观察组总有效率90.6%,对照组总有效率71.9%,观察组疗效明显优于对照组,且治疗后观察组LDH、AST和CK下降较对照组明显。结论黄芪注射液辅助治疗小儿病毒性心肌炎疗效确切,且安全性较高,值得在临床中推广应用。
Objective To observe the clinical efficacy of astragalus injection in the treatment of viral myocarditis in children. Methods 64 cases of viral myocarditis admitted to our hospital were divided into control group and observation group, 32 cases in the control group were treated with Western medicine alone. The observation group was treated with astragalus injection on the basis of the control group, Months later, the changes of LDH, AST and CK before and after treatment were compared between the two groups. Results The total effective rate was 90.6% in the observation group and 71.9% in the control group. The curative effect of the observation group was obviously better than that of the control group. The decrease of LDH, AST and CK in the observation group was more obvious than that of the control group. Conclusion Astragalus injection adjuvant treatment of children with viral myocarditis effective and safe, it is worth in the clinical application.